Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ator NA et al. – Elimination of efficacy at the alpha1 subtype of the GABA/benzodiazepine receptor is not sufficient to eliminate abuse liability but may do so when coupled with reduced alpha2/3 subtype efficacy.

Related Articles

Early-Life Blockade of 5-HT1A Receptors Alters Adult Anxiety Behavior and Benzodiazepine Sensitivity
Biological Psychiatry, 10/12/09    Relevance Score: 83%

Transrectal Ultrasound-Guided Prostatic Biopsy: Midazolam, the Ideal Analgesic
Urologia Internationalis, 10/16/09    Relevance Score: 80%

Endoscopist-Directed Administration of Propofol: A Worldwide Safety Experience
Gastroenterology, 10/06/09    Relevance Score: 80%

Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol
Expert Opinion on Investigational Drugs, 10/06/09    Relevance Score: 80%

Translocator Protein Blockade Reduces Prostate Tumor Growth
Clinical Cancer Research, 10/01/09    Relevance Score: 80%

Today in Basic Science...keeping you current

A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09

The Basic Helix-loop-helix Proteins DEC1 and DEC2 Function as Corepressors of Retinoid X Receptors
Molecular Pharmacology, 11/25/09

Control of GluR2 translational initiation by its alternative 3'UTRs
Molecular Pharmacology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address